Current Opinion in Rheumatology was launched in 1989. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The field of Rheumatology is divided into 15 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
Allan C. Gelber
Allan C. Gelber is Associate Professor of Medicine and Deputy Director for Education and Faculty Development in the Division of Rheumatology at the Johns Hopkins University School of Medicine, USA. He holds a joint appointment in the Department of Epidemiology at the Bloomberg School of Public Health and is Associate Faculty at the Welch Center for Prevention, Epidemiology and Clinical Research, USA. Dr Gelber is a graduate of the Johns Hopkins University School of Medicine and received both his MPH and PhD degrees (the latter in clinical investigation) at the Bloomberg School. He pursued internship and residency training in internal medicine at Duke University, USA, and then undertook fellowship training in rheumatology at Johns Hopkins.
Dr Gelber's research activity applies the tools of clinical epidemiology across the spectrum of rheumatic disorders. His investigative pursuits include recent studies identifying predictors of prevalent and incident gout, outcomes in scleroderma, and cardiovascular disease burden and risk in rheumatoid arthritis. He has been actively involved in mentoring medical and graduate students, as well as rheumatology fellows and junior faculty colleagues in these investigative pursuits. Dr Gelber serves as an Associate Editor at Arthritis Care & Research.
In addition, Dr Gelber has had an active role as an educator in the rheumatic diseases. He previously served as Fellowship Program Director at Johns Hopkins from 2001 to 2011. In the subsequent two year period, he has shifted his primary educational focus from rheumatology fellows to medical students, as well as to internal medicine house staff on the Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center campuses. He directs the Musculoskeletal Section of the Genes-to-Society Course to 2nd year medical students at Johns Hopkins and at the Perdana University Graduate School of Medicine in Kuala Lumpur, Malaysia.
Dr Hyon Choi received his rheumatology fellowship training at the Harvard Medical School and Massachusetts General Hospital, USA, and his master and doctorate degrees in epidemiology from Harvard University. He is a Professor of Medicine and Public Health at Boston University, USA, and a Research Scientist at Brigham and Women's Hospital, USA, and the Arthritis Research Centre of Canada, Canada. Dr Choi has been a leading gout clinician-investigator for more than a decade, as reflected in his funding (US NIH grants as well as industry grants), over 150 publications (including those published in New Eng J Med, JAMA, Lancet, Ann Int Med, BMJ, Arch Int Med, Am J Med, Ann Rheum Dis, A&R) and his reviewer activities on the topic for these major journals. Dr Choi has led an NIH-funded genome-wide association study, which became a critical component of an important global consortium paper (Nature Genetics). He has been invited to give lectures at many key international meetings and has taught the meet-the-professor session about the optimal management of gout at the American College of Rheumatology Meeting. Furthermore, he has served as a productive mentor for many rheumatology trainees, residents, and PhD and undergrad students for the last decade.
Iain McInnes is an international authority on the pathogenesis and treatment of inflammatory arthritis. His early studies identified the expression/functional importance of several novel cytokines in rheumatoid arthritis (RA) synovitis, particularly IL-15 and IL-18. Subsequent studies identified numerous novel regulators of synovial cytokine production. Parallel studies explore mechanisms underpinning vascular co-morbidity in autoimmune disease. Dr McInnes has published extensively in, and edited, journals of high impact. He is active in the national academic community serving on or chairing the Arthritis Research (UK) Research Committee, MRC Panel for Clinical Training Fellowships. He is Director of the Scottish Clinical Pharmacology and Pathology Training Programme (MRC) and Deputy Director of the Scottish Translational Medicine Initiative. He is the Director of the recently created Arthritis Research UK Rheumatoid Arthritis Pathogenesis Centre of Excellence and moreover has just created the GLAZgo Discovery Centre in a unique discovery platform to innovate new drug development.
He has participated extensively in the workings of the European League Against Rheumatism (EULAR) – formerly as Chair of the Scientific Committee of EULAR, and now as the first appointee as Chairman of the European Rheumatology Research Foundation. He has received numerous invited lectureships and professorships, including for example the Cochrane Lecture, UAB, 2012; The Droitwich Lecture, BSR/BHPR 2011; The Gerald Weissmann Lecture in Rheumatology, New York 2013; The Dunlop-Dotteridge Lecture, Canada 2010; The JL Woodbury Lecture in Rheumatology, Canda, 2006, Nana Svartz Lecture, Swedish Medical Society, 2009; Visiting Professor, UCSD 2008; Pual Bilka Visiting Professor, Mayo Clinic 2013; Kroc Lecture, Washington University Medical School, USA 2014. He was elected FRSE in 2008, and FMedSci in 2012.